A variant in the CHEK2 promoter at a methylation site relieves transcriptional repression and confers reduced risk of lung cancer.
Zhang S, Lu J, Zhao X, Wu W, Wang H, Lu J, Wu Q, Chen X, Fan W, Chen H, Wang F, Hu Z, Jin L, Wei Q, Shen H, Huang W, Lu D.
Zhang S, et al. Among authors: shen h.
Carcinogenesis. 2010 Jul;31(7):1251-8. doi: 10.1093/carcin/bgq089. Epub 2010 May 12.
Carcinogenesis. 2010.
PMID: 20462940